Ligand Pharmaceuticals | LGND - 债务

股票价格
207.78
每天变化
-0.11 -0.05%
每月一次
-10.35%
每年
98.04%
Q2 预测
208.92


金融业
股票价格
USD
资产
USD 1.53B
现金及等价物
USD 115.08M
销售成本
USD 11.37M
流动资产
USD 865.42M
流动负债
USD 40.67M
债务
USD 451.49M
EBIT
USD 60.33M
EBITDA
USD 66.78M
员工
68
EPS每股收益
USD 1.63
股本和储备
USD 997.32M
销售毛利
USD 48.45M
债务利息支出
USD 1.79M
利息收入
USD 6.39M
贷款资金
USD 446.19M
市值
USD 3.68B
净收入
USD -13.35M
营业费用
USD 34.35M
营业利润
USD 60.33M
普通股股本
USD 19.66M
PE价格收益
56.5
税前利润
USD 56.78M
销售收入
USD 51.72M
销售和管理费用
USD 20.84M
股票
USD 13.27M
贸易债权人
USD 37.11M
应收帐款人
USD 54.8M


债务 更改 日
Agenus USD 35.54M 2.34M 2025-03
Amgen USD 54.6B 17M 2025-12
Anika Therapeutics USD 0 0 2025-03
Arrowhead Research USD 312.77M 53.52M 2025-12
Baxter International USD 9.78B 68M 2025-12
Bristol-Myers Squibb USD 47.14B 3.9B 2025-12
Eli Lilly USD 42.5B 3.6M 2025-12
Enanta Pharmaceuticals USD 1.35M 0 2024-12
Enviri Corporation USD 1.44B 3.08M 2024-12
Gilead Sciences USD 24.94B 5M 2025-12
GlaxoSmithKline GBP 19.06B 1.34B 2026-03
Glaxosmithkline GBP 17.75B 396M 2025-09
Heron Therapeutics USD 149.65M 157K 2024-09
Insmed USD 727.62M 275K 2026-03
Intrexon USD 0 13.82M 2024-06
Ionis Pharmaceuticals USD 2.34B 9.5M 2026-03
Karyopharm Therapeutics USD 299.23M 35.14M 2025-12
Ligand Pharmaceuticals USD 451.49M 494K 2025-12
MacroGenics USD 37.01M 238K 2025-09
Merck USD 49.34B 7.97B 2025-12
Pacira USD 367.66M 4.53M 2026-03
Pfizer USD 63.73B 231M 2026-03
Rigel Pharmaceuticals USD 59.69M 90K 2024-06
Sangamo BioSciences USD 0 0 2022-06
Veracyte USD 39.65M 799K 2025-12